Integrated clinicopathological and molecular profiling of papillary thyroid carcinoma identifies predominant BRAF and TERT promoter mutations: a cross-sectional study
Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · 07.07.2026
DOI: 10.4081/jbr.2026.14951 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, online erschienen am 07.07.2026. Verfasst von Rawezh Qadir M. Salih und 2 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Papillary Thyroid Carcinoma (PTC) exhibits diverse genetic alterations that influence tumor behavior and clinical outcomes. This study aimed to characterize the spectrum of somatic mutations in PTC using targeted Next-Generation Sequencing (NGS) and to evaluate their associations with clinicopathological, metabolic, and stress-related factors. A Prospective study was conducted on 45 patients newly diagnosed with PTC who underwent total thyroidectomy between December 2024 and February 2025. Formalin-Fixed, Paraffin-Embedded (FFPE) tumor tissues were analyzed using a targeted NGS panel encompassing 35 PTC-related genes. Bioinformatics analysis was performed using Genome Analysis Toolkit (GATK) and ANNOtate VARiation (ANNOVAR) for variant detection and annotation. Clinicopathological variables age, sex, Body Mass Index (BMI), tumor size, laterality, thyroid ultrasound findings, Thyroid Imaging Reporting and Data System (TI-RADS) level and stress exposure were statistically correlated with detected mutations using the chi-square test; a p < 0.05 value was considered as significant. All patients exhibited at least one genetic alteration, with 171 somatic mutations identified (average 3.8 per patient). The most frequent mutation was BRAF V600E (73.3%), followed by TERT promoter (28.9%), MET (24.4%), NRAS (22.2%), and DICER1 (20%). BRAF V600E mutations were significantly more common in tumors ≤ 1.2 cm (p = 0.037) and in right-lobe lesions (p = 0.049). RAS mutations correlated with smaller tumor size (p = 0.021), while TERT mutations were associated with stress exposure (p = 0.001). BRAF, RAS, and TERT mutations were also significantly more frequent among overweight and obese patients (p = 0.047, 0.046, and 0.040, respectively). Age-wise, BRAF and RAS mutations predominated in younger patients (≤ 40 years), whereas TERT mutations occurred unexpectedly more often in this group. BRAF V600E and TERT promoter mutations represent the dominant molecular events in PTC and demonstrate significant associations with tumor size, BMI, stress status, and patient age, suggesting that both metabolic and psychosocial factors may influence thyroid tumorigenesis.
Zitieren
APA
Salih, R. Q. M., Mohammed, D. A., & Hamawandi, N. M. (2026). Integrated clinicopathological and molecular profiling of papillary thyroid carcinoma identifies predominant BRAF and TERT promoter mutations: a cross-sectional study. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale. https://doi.org/10.4081/jbr.2026.14951
Vancouver
Salih RQM, Mohammed DA, Hamawandi NM. Integrated clinicopathological and molecular profiling of papillary thyroid carcinoma identifies predominant BRAF and TERT promoter mutations: a cross-sectional study. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale. 2026. doi:10.4081/jbr.2026.14951
BibTeX
@article{Salih2026,
author = {Salih, Rawezh Qadir M. and Mohammed, Dlnya A. and Hamawandi, Nizar M.T.},
title = {Integrated clinicopathological and molecular profiling of papillary thyroid carcinoma identifies predominant BRAF and TERT promoter mutations: a cross-sectional study},
journal = {Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale},
year = {2026},
doi = {10.4081/jbr.2026.14951}
}
EUVIMED